What still needs checking
- Retail rollout status is now verified from the commission: dispensary applications have not opened. Future cannabis checkout-tax treatment remains unresolved; the general drug exemption does not expressly settle recommendation-based cannabis, and proposed LB677 or introduced LB1235 tax rates are not operative.
- Prior 2025 summary treated unpassed LB677 provisions as law; corrected against operative statutes and bill history.
Possession and use
Nebraska has not established general adult-use legalization. Under the Medical Cannabis Patient Protection Act, a qualified patient with a valid written practitioner recommendation may use, possess and acquire up to five ounces of cannabis for a medical condition. The statutory definition includes flower and concentrates and excludes the weight of non-cannabis ingredients in certain preparations.
The operative definition imposes no separate two-ounce flower sublimit. Flower and concentrates both count as cannabis toward the medical allowance; non-cannabis ingredients in specified preparations are excluded from the weight calculation. This protection is a medical exception, not a general five-ounce allowance for adults.
Medical access
Voters approved medical initiatives, and the Medical Cannabis Commission oversees the licensed supply chain. The patient-protection statute defines a qualified patient by a written recommendation from a licensed practitioner; a minor also needs permission from a parent or legal guardian. A recommendation is valid for two years unless the practitioner specifies a shorter period. The commission says permanent regulations were approved in July 2026.
The commission distinguishes current permanent regulations from amendments still going through formal rulemaking. Its July 2026 rules had Attorney General and Governor approval, while the August proposals had not yet become effective on the commission's October timeline. A patient should use the operative rules, not a draft or an anticipated 2027 application process.
Home cultivation
Nebraska's patient-protection statute covers medical use, possession and acquisition, but does not authorize personal cultivation. Under the separate controlled-substances statute, production includes planting and cultivation, and unauthorized manufacture of a controlled substance is unlawful. A practitioner recommendation does not provide a home-grow right.
Buying legally
Nebraska has a medical licensing framework, but the commission says dispensary applications have not yet opened. As checked on October 23, 2026, its application page accepts only manufacturer applications and describes a further manufacturer process expected in early 2027. Medical possession protection therefore should not be mistaken for access to an operating Nebraska dispensary. No retail opening date is promised.
Taxes
LB677 was indefinitely postponed, and the medical-cannabis tax in the introduced version of LB1235 was omitted from its enacted slip law. Neither proposed rate is an enacted checkout tax. Nebraska lists a general 5.5% state sales-tax rate, with possible local tax, but the tax treatment of a future medical-cannabis dispensary transaction has not been confirmed from an operative cannabis-specific tax ruling or an operating storefront.
The general prescription-drug exemption does not expressly settle medical cannabis sold on a written recommendation. This guide therefore gives neither a tax-exempt claim nor a final cannabis checkout percentage before authoritative guidance resolves that application.
Travel and transport
The state patient protection applies to qualified patients under Nebraska law; it gives no permission to carry cannabis across state borders. A visiting patient should not assume that an out-of-state card alone establishes the Nebraska statutory written recommendation. Verify eligibility before travel, and do not use cannabis while driving.
Sources and remaining checks
We checked the sources below on the date shown above. Rules may have changed since then. Check the current rules before making a decision, and read the remaining questions noted in this guide.
- Nebraska Medical Cannabis Commission rules. Permanent rules approved July 2026; proposed amendments still in rulemaking.
- Nebraska Governor permanent-rules notice. July 1, 2026 approval announcement.
- Nebraska Revised Statute 71-24,104: patient definitions. Directly read October 23, 2026; up to five ounces, no separate flower sublimit, written recommendation.
- Nebraska Revised Statute 71-24,105: patient protection. Directly read October 23, 2026; protected use, possession and acquisition for qualified patients and caregivers.
- Nebraska Revised Statute 71-24,107: regulation definitions. Directly read October 23, 2026; registered establishment and regulation definitions.
- Nebraska LB677 official actions. Directly read October 23, 2026; LB677 indefinitely postponed April 17, 2026.
- Nebraska LB1235 enacted slip law. Approved April 7, 2026; final medical-cannabis provisions concern commission funding, fees and background checks, not the introduced retail tax.
- Nebraska Department of Revenue sales and use tax rates. General 5.5% state sales tax, with local rates that vary by location; cannabis checkout application not confirmed.
- Nebraska Revised Statute 28-401 controlled-substance definitions. Production includes planting and cultivation; manufacture includes production.
- Nebraska Revised Statute 28-416 prohibited acts. Unauthorized manufacture of a controlled substance is prohibited.
- Nebraska Revised Statute 28-405 controlled-substance schedules. Marijuana appears in Schedule I.
- Nebraska Medical Cannabis Commission: how to apply. Directly read October 23, 2026; dispensary application period has not opened; only manufacturer applications currently accepted. Some older emergency-rule references remain on this page, so the separate rules page governs adopted-rule status.
- Nebraska Revenue Regulation 1-050: medicines and medical equipment. Directly read October 23, 2026; prescription-drug exemption has conditions. Does not expressly determine whether the cannabis written-recommendation framework qualifies.
No professional legal review is claimed. Check official sources and the verification notes below.